Bibliographic information
GuidelineConsolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year of Publication2013
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
Countries should discontinue stavudine (d4T) use in first-line regimens because of its well-recognized metabolic toxicities
Recommended in favor
Strong
Certainty of evidence
Moderate
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year2016
InstitutionWHO